Loading...
XTSE
CRRX
Market cap136mUSD
Jul 09, Last price  
2.97CAD
1D
0.00%
1Q
14.23%
Jan 2017
-74.83%
IPO
-63.78%
Name

CareRx Corp

Chart & Performance

D1W1MN
P/E
—
P/S
0.51
EPS
—
Div Yield, %
—
Shrs. gr., 5y
40.57%
Rev. gr., 5y
24.09%
Revenues
367m
-1.09%
9,420,98812,321,11614,251,04515,795,22636,623,00062,482,000200,992,000436,651,000455,864,000308,074,000162,421,000167,363,000168,967,000123,742,000124,626,000162,196,000262,630,000381,727,000370,746,000366,714,000
Net income
-5m
L-16.73%
-348,08849,468754,686952,1861,640,0004,328,000-8,982,000-7,258,000-91,091,000-57,447,00046,083,000-19,677,0001,846,000-31,093,000-45,677,000-18,183,000-22,730,000-34,353,000-5,405,000-4,501,000
CFO
38m
+38.78%
67,94286,696915,891433,2623,031,0005,945,0007,598,00015,314,00020,204,00019,719,00029,447,0001,700,00016,073,0006,592,0006,355,000229,0007,269,00022,333,00027,375,00037,991,000
Earnings
Aug 06, 2025

Profile

CareRx Corporation, together with its subsidiaries, provides specialty pharmacy services to seniors in Canada. The company operates a network of pharmacy fulfilment centers that provide chronic medication and other specialty clinical pharmacy services. It serves approximately 50,000 residents in approximately 900 seniors and other communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is headquartered in Toronto, Canada.
URL
https://www.carerx.ca/
IPO date
Sep 04, 2002
Employees
1,444
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
366,714
-1.09%
370,746
-2.88%
381,727
45.35%
Cost of revenue
291,406
363,520
306,225
Unusual Expense (Income)
NOPBT
75,308
7,226
75,502
NOPBT Margin
20.54%
1.95%
19.78%
Operating Taxes
32
(4,190)
(1,543)
Tax Rate
0.04%
NOPAT
75,276
11,416
77,045
Net income
(4,501)
-16.73%
(5,405)
-84.27%
(34,353)
51.14%
Dividends
Dividend yield
Proceeds from repurchase of equity
(801)
14,623
1,007
BB yield
0.65%
-15.84%
-0.83%
Debt
Debt current
8,120
12,720
10,006
Long-term debt
111,854
115,938
153,662
Deferred revenue
3,233
Other long-term liabilities
1,997
2,774
3,727
Net debt
110,890
121,629
135,297
Cash flow
Cash from operating activities
37,991
27,375
22,333
CAPEX
(5,588)
(4,728)
(13,613)
Cash from investing activities
(7,918)
(12,314)
(16,598)
Cash from financing activities
(28,018)
(36,403)
(12,989)
FCF
79,305
9,136
64,492
Balance
Cash
9,084
7,029
28,371
Long term investments
Excess cash
9,285
Stockholders' equity
43,918
47,906
29,959
Invested Capital
168,856
182,289
197,356
ROIC
42.87%
6.01%
38.74%
ROCE
44.60%
3.96%
35.84%
EV
Common stock shares outstanding
60,254
57,350
47,596
Price
2.06
27.95%
1.61
-37.11%
2.56
-55.01%
Market cap
124,123
34.43%
92,333
-24.22%
121,846
-38.57%
EV
235,013
213,962
257,143
EBITDA
94,498
27,202
95,567
EV/EBITDA
2.49
7.87
2.69
Interest
9,182
14,270
15,221
Interest/NOPBT
12.19%
197.48%
20.16%